The present invention provides an anti-CD81 antibody that is useful as a pharmaceutical product for human use. Specifically, the present invention provides an anti-human CD81 antibody that can bind to a peptide domain consisting of an amino acid sequence represented by amino acid Nos. 80 to 175 in the amino acid sequence represented by SEQ ID NO: 22.